Login / Signup

Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases.

Caoilfhionn Marie ConnollyJake A RuddyBrian J BoyarskyRobin K AveryWilliam A WerbelDorry L SegevJacqueline Garonzik-WangJulie J Paik
Published in: Annals of the rheumatic diseases (2021)
Keyphrases
  • sars cov
  • rheumatoid arthritis
  • respiratory syndrome coronavirus
  • binding protein
  • coronavirus disease